Provided by Tiger Trade Technology Pte. Ltd.

Stifel

79.76
+0.07000.09%
Post-market: 79.760.00000.00%19:30 EDT
Volume:724.84K
Turnover:57.73M
Market Cap:12.04B
PE:14.26
High:80.72
Open:79.21
Low:78.85
Close:79.69
52wk High:89.83
52wk Low:67.81
Shares:151.00M
Float Shares:141.93M
Volume Ratio:0.63
T/O Rate:0.51%
Dividend:1.33
Dividend Rate:1.66%
EPS(TTM):5.59
EPS(LYR):3.91
ROE:16.43%
ROA:2.25%
PB:2.26
PE(LYR):20.38

Loading ...

Stifel Nicolaus Keeps Their Buy Rating on SmartStop Self Storage REIT, Inc. (SMA)

TIPRANKS
·
Aug 07

Solaris Energy Infrastructure (SEI) Gets a Buy from Stifel Nicolaus

TIPRANKS
·
Aug 07

Stifel Nicolaus Sticks to Its Hold Rating for Curtiss-Wright (CW)

TIPRANKS
·
Aug 07

Stifel Nicolaus Keeps Their Buy Rating on HMH Holding Inc. Class A (HMH)

TIPRANKS
·
Aug 07

Braveheart Bio Poised to Surge in New York Debut After Upsized $383 Million IPO

Reuters
·
Aug 06

ZoomInfo Technologies is Maintained at Hold by Stifel

Dow Jones
·
Aug 06

Kratos is Maintained at Buy by Stifel

Dow Jones
·
Aug 06

LCI Industries is Maintained at Buy by Stifel

Dow Jones
·
Aug 06

Flutter Entertainment is Maintained at Buy by Stifel

Dow Jones
·
Aug 06

Eos Energy Enterprises is Maintained at Buy by Stifel

Dow Jones
·
Aug 06

AbCellera Biologics is Maintained at Buy by Stifel

Dow Jones
·
Aug 06

River City Bank Set for NASDAQ Debut After Downsized $122 Million US IPO

Reuters
·
Aug 06

Kratos Defense price target lowered to $115 from $134 at Stifel

TIPRANKS
·
Aug 06

LCI Industries price target lowered to $130 from $137 at Stifel

TIPRANKS
·
Aug 06

Stifel Nicolaus Keeps Their Buy Rating on Kratos Defense (KTOS)

TIPRANKS
·
Aug 06

Stifel Nicolaus Keeps Their Buy Rating on Western Midstream Partners (WES)

TIPRANKS
·
Aug 06

Stifel Nicolaus Keeps Their Buy Rating on NewAmsterdam Pharma Company (NAMS)

TIPRANKS
·
Aug 06

Stifel Nicolaus Reaffirms Their Buy Rating on Power Integrations (POWI)

TIPRANKS
·
Aug 06

Stifel Nicolaus Reaffirms Their Buy Rating on Forward Air (FWRD)

TIPRANKS
·
Aug 06

Stifel Nicolaus Reaffirms Their Buy Rating on Enliven Therapeutics (ELVN)

TIPRANKS
·
Aug 06